ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,184, issued on Sept. 9, was assigned to BTG INTERNATIONAL INC. (West Conshohocken, Pa.).
"Iloprost compositions and formulations thereof" was invented by Wade W. Benton (Emerald Hills, Calif.) and Kevin A. Christal (Burlingame, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to treatment of systemic sclerosis with symptomatic Raynaud's Phenomenon by intravenous or subcutaneous administration of iloprost or a pharmaceutically acceptable salt thereof."
The patent was filed on Jan. 13, 2025, under Application No. 19/018,702.
*For further information, including images, charts and tables, please visit: ht...